The role of microbiota in liver diseases

The role of microbiota in liver diseases - RIVE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010513

Enrollment

350

Registered

2016-08-05

Start date

2017-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K83.0 K83.1 K83.8 K83.9 K87.0

Interventions

Group 1: Analysis of the microbiota in patients with bile-duct associated diseases Group 2: Analysis of the microbiota in patients without bile-duct associated diseases

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: bile-duct associated liver diseases

Exclusion criteria

Exclusion criteria: Unable to give consent Pregnany

Design outcomes

Primary

Measure	Time frame
Analyzation of changes in composition and distribution of the microbiome with NGS (Next Generation Sequencing) in patients with liver disease, compared to a healthy control group during in-hospitalization.	—

Secondary

Measure	Time frame
Analysis of microbial diversity, depending on the underlying liver disease	—

Countries

Germany

Contacts

Public ContactHenrike Lenzen

Medizinische Hochschule Hannover

lenzen.henrike@mh-hannover.de0511-532-4340

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026